Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-07-20

FDA Approved: PYRIDOSTIGMINE BROMIDE — Original Application (Method Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved an original application for pyridostigmine bromide by Method Pharmaceuticals LLC, adding a generic version of the cholinesterase inhibitor used…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pyridostigmine bromide (Pyridostigmine bromide)

Snippet

ORIG AP for PYRIDOSTIGMINE BROMIDE (PYRIDOSTIGMINE BROMIDE)